China News Service, Ruili, July 5 (Miao Chao, Han Shuainan) Ruili City, Yunnan Province held a press conference on July 5, stating that from 0:00 to 24:00 on July 4, 3 new local confirmed cases in Yunnan Province (Chinese nationality) (2 cases, 1 case from Myanmar), the above 3 confirmed cases were discovered by Ruili City during the normalized full-time nucleic acid test carried out according to the plan, and they are all in the report.

  Ruili City is located in the western part of Yunnan Province. It is connected to the mountains and rivers of Myanmar on three sides in the northwest, southwest and southeast.

This is from April 21 to July 3, 73 days after Yunnan Province maintained “zero new” of local confirmed cases, another new local confirmed case was added.

  At present, combined with epidemiological history, clinical manifestations and laboratory test results, all confirmed cases of new coronary pneumonia have been diagnosed (2 cases of common type and 1 case of mild type), and the flow adjustment work is proceeding in an orderly manner.

  Ruili City Mayor Shang Labian said that after receiving the case report, Ruili City took immediate action to immediately initiate Level III response to public health emergencies, and close the Li Rui channel and online Li Rui approval functions.

The residential areas of the 3 confirmed cases were closed for management, and the Jiejiao Bridge was temporarily closed to prohibit people and vehicles from going out.

At present, residents in the Jiejiao area have implemented home isolation management.

The three-level disease control, health, and public security departments of Yunnan Province, Dehong Prefecture, and Ruili City jointly carried out circulation work, and further tracked and investigated the trajectories of cases, close contacts, and sub-closed personnel. The other four counties, cities, and prefectures in the prefecture have been investigated. 903 medical personnel from direct medical institutions were transferred to Ruili to carry out epidemiological investigations, nucleic acid sampling and testing, and medical treatment.

(Finish)